These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 25688146)

  • 1. Doing the right things and doing them the right way: association between hospital guideline adherence, dosing safety, and outcomes among patients with acute coronary syndrome.
    Mehta RH; Chen AY; Alexander KP; Ohman EM; Roe MT; Peterson ED
    Circulation; 2015 Mar; 131(11):980-7. PubMed ID: 25688146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.
    Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
    Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.
    Alexander KP; Chen AY; Roe MT; Newby LK; Gibson CM; Allen-LaPointe NM; Pollack C; Gibler WB; Ohman EM; Peterson ED;
    JAMA; 2005 Dec; 294(24):3108-16. PubMed ID: 16380591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between hospital process performance and outcomes among patients with acute coronary syndromes.
    Peterson ED; Roe MT; Mulgund J; DeLong ER; Lytle BL; Brindis RG; Smith SC; Pollack CV; Newby LK; Harrington RA; Gibler WB; Ohman EM
    JAMA; 2006 Apr; 295(16):1912-20. PubMed ID: 16639050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative.
    Alexander KP; Chen AY; Newby LK; Schwartz JB; Redberg RF; Hochman JS; Roe MT; Gibler WB; Ohman EM; Peterson ED;
    Circulation; 2006 Sep; 114(13):1380-7. PubMed ID: 16982940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged emergency department stays of non-ST-segment-elevation myocardial infarction patients are associated with worse adherence to the American College of Cardiology/American Heart Association guidelines for management and increased adverse events.
    Diercks DB; Roe MT; Chen AY; Peacock WF; Kirk JD; Pollack CV; Gibler WB; Smith SC; Ohman M; Peterson ED
    Ann Emerg Med; 2007 Nov; 50(5):489-96. PubMed ID: 17583379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical records and quality of care in acute coronary syndromes: results from CRUSADE.
    Dunlay SM; Alexander KP; Melloni C; Kraschnewski JL; Liang L; Gibler WB; Roe MT; Ohman EM; Peterson ED
    Arch Intern Med; 2008 Aug; 168(15):1692-8. PubMed ID: 18695085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.
    Mehta RH; Roe MT; Mulgund J; Ohman EM; Cannon CP; Gibler WB; Pollack CV; Smith SC; Ferguson TB; Peterson ED
    J Am Coll Cardiol; 2006 Jul; 48(2):281-6. PubMed ID: 16843176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines).
    Kadakia MB; Desai NR; Alexander KP; Chen AY; Foody JM; Cannon CP; Wiviott SD; Scirica BM;
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1166-77. PubMed ID: 21087753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guideline implementation research: exploring the gap between evidence and practice in the CRUSADE Quality Improvement Initiative.
    Blomkalns AL; Roe MT; Peterson ED; Ohman EM; Fraulo ES; Gibler WB
    Acad Emerg Med; 2007 Nov; 14(11):949-54. PubMed ID: 17967956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Glycoprotein IIb/IIIa Inhibition in Contemporary Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the National Cardiovascular Data Registry.
    Safley DM; Venkitachalam L; Kennedy KF; Cohen DJ
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1574-82. PubMed ID: 26493250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
    Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of in-hospital guideline adherence and longitudinal postdischarge mortality in older patients with non-ST-segment elevation myocardial infarction.
    Shah BR; O'Brien EC; Roe MT; Chen AY; Peterson ED
    Am Heart J; 2015 Aug; 170(2):273-280.e1. PubMed ID: 26299224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative.
    Bottorff MB; Nutescu EA; Spinler S
    Pharmacotherapy; 2007 Aug; 27(8):1145-62. PubMed ID: 17655514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial.
    Toleva O; Westerhout CM; Senaratne MP; Bode C; Lindroos M; Sulimov VA; Montalescot G; Newby LK; Giugliano RP; Van de Werf F; Armstrong PW
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):934-42. PubMed ID: 24976083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.